543 related articles for article (PubMed ID: 35887358)
1. Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.
Lara-Ureña N; Jafari V; García-Domínguez M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887358
[TBL] [Abstract][Full Text] [Related]
2. The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells.
Shi X; Du Y; Li S; Wu H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408996
[TBL] [Abstract][Full Text] [Related]
3. Mapping the SUMOylated landscape.
Eifler K; Vertegaal AC
FEBS J; 2015 Oct; 282(19):3669-80. PubMed ID: 26185901
[TBL] [Abstract][Full Text] [Related]
4. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
5. Function and regulation of SUMO proteases.
Hickey CM; Wilson NR; Hochstrasser M
Nat Rev Mol Cell Biol; 2012 Dec; 13(12):755-66. PubMed ID: 23175280
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms in SUMO conjugation.
Varejão N; Lascorz J; Li Y; Reverter D
Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228
[TBL] [Abstract][Full Text] [Related]
7. SUMO proteases as potential targets for cancer therapy.
Bialik P; Woźniak K
Postepy Hig Med Dosw (Online); 2017 Dec; 71(0):997-1004. PubMed ID: 29225200
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a Dual SENP1 and SENP2 Inhibitor.
Brand M; Bommeli EB; Rütimann M; Lindenmann U; Riedl R
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292935
[TBL] [Abstract][Full Text] [Related]
9. SUMO-SIM interactions: From structure to biological functions.
Lascorz J; Codina-Fabra J; Reverter D; Torres-Rosell J
Semin Cell Dev Biol; 2022 Dec; 132():193-202. PubMed ID: 34840078
[TBL] [Abstract][Full Text] [Related]
10. SUMO pathway components as possible cancer biomarkers.
Mattoscio D; Chiocca S
Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214
[TBL] [Abstract][Full Text] [Related]
11. SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation.
Li C; Boutet A; Pascariu CM; Nelson T; Courcelles M; Wu Z; Comtois-Marotte S; Emery G; Thibault P
J Proteome Res; 2023 Mar; 22(3):812-825. PubMed ID: 36723483
[TBL] [Abstract][Full Text] [Related]
12. Current Status of SUMOylation Inhibitors.
Brackett CM; Blagg BSJ
Curr Med Chem; 2021; 28(20):3892-3912. PubMed ID: 32778019
[TBL] [Abstract][Full Text] [Related]
13. The function of SUMOylation and its crucial roles in the development of neurological diseases.
Chen X; Zhang Y; Wang Q; Qin Y; Yang X; Xing Z; Shen Y; Wu H; Qi Y
FASEB J; 2021 Apr; 35(4):e21510. PubMed ID: 33710677
[TBL] [Abstract][Full Text] [Related]
14. DeSUMOylating isopeptidase: a second class of SUMO protease.
Shin EJ; Shin HM; Nam E; Kim WS; Kim JH; Oh BH; Yun Y
EMBO Rep; 2012 Apr; 13(4):339-46. PubMed ID: 22370726
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic sumoylation by PIAS-type Siz1-SUMO ligase.
Takahashi Y; Iwase M; Strunnikov AV; Kikuchi Y
Cell Cycle; 2008 Jun; 7(12):1738-44. PubMed ID: 18583943
[TBL] [Abstract][Full Text] [Related]
16. Pli1(PIAS1) SUMO ligase protected by the nuclear pore-associated SUMO protease Ulp1SENP1/2.
Nie M; Boddy MN
J Biol Chem; 2015 Sep; 290(37):22678-85. PubMed ID: 26221037
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
[TBL] [Abstract][Full Text] [Related]
18. Regulation of post-translational modification in breast cancer treatment.
Heo KS
BMB Rep; 2019 Feb; 52(2):113-118. PubMed ID: 30638182
[TBL] [Abstract][Full Text] [Related]
19. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Studies Reveal a Sequential Mode of Chain Processing by the Yeast SUMO (Small Ubiquitin-related Modifier)-specific Protease Ulp2.
Eckhoff J; Dohmen RJ
J Biol Chem; 2015 May; 290(19):12268-81. PubMed ID: 25833950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
